Gwendolyn P Quinn1, Rebecca D Pentz2, Teresita Muñoz-Antonia3, Theresa A Boyle4, Matthew B Schabath5, Christie L Pratt6, Andrea Shaffer6, Luisa F Duarte7, Meghan Bowman-Curci7, Scott J Antonia8, Alberto A Chiappori8, Benjamin C Creelan8, Jhanelle E Gray8, Charles C Williams8, Eric B Haura8. 1. Division of Population Science, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, United States; New York University School of Medicine, 500 1st Ave, New York, NY 10012, United States. Electronic address: gwendolyn.quinn@nyumc.org. 2. Winship Cancer Institute, Emory University School of Medicine, 1365 Clifton Rd., Atlanta, GA 30322, United States. 3. Morsani College of Medicine, Department of Oncologic Science, University of South Florida, 12901 Bruce B Downs Blvd., Tampa, FL 33612, United States; Tumor Biology Department, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, United States. 4. Morsani College of Medicine, Department of Oncologic Science, University of South Florida, 12901 Bruce B Downs Blvd., Tampa, FL 33612, United States; Anatomic Pathology Department, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, United States. 5. Division of Population Science, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, United States; Morsani College of Medicine, Department of Oncologic Science, University of South Florida, 12901 Bruce B Downs Blvd., Tampa, FL 33612, United States. 6. Department of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, United States. 7. Division of Population Science, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, United States. 8. Morsani College of Medicine, Department of Oncologic Science, University of South Florida, 12901 Bruce B Downs Blvd., Tampa, FL 33612, United States; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, United States.
Abstract
OBJECTIVE: The collection of posthumous tissue from advanced stage lung cancer patients is beneficial to medical science. Recruiting living patients to a Rapid Tissue Donation Program (RTD) poses several psychosocial challenges and little is known about perceptions of joining this type of program. This study qualitatively examined perceptions of advanced stage lung cancer patients (n=14) participating in a lung cancer RTD program, their NoK (n=11), and physicians (n=6) at the Thoracic Oncology Clinic at H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida USA. METHODS: Semi-structured interviews were conducted with participants and interview transcripts were analyzed using the constant comparison method. RESULTS: Majority of patients joined to give back to research, discussed participation with family members, and desired for family to receive information about the use of the tissue after their death. All participating NoK were supportive of their family member's decision. Physicians described the program as running smoothly, but provided suggestions for process improvements. CONCLUSION: Participants joined with intention to give back to research community and families were supportive of loved one's participation in RTD. Physicians agreed with overall process. PRACTICE IMPLICATIONS: Key factors for a successful RTD program is tailoring to institutional and individual needs.
OBJECTIVE: The collection of posthumous tissue from advanced stage lung cancerpatients is beneficial to medical science. Recruiting living patients to a Rapid Tissue Donation Program (RTD) poses several psychosocial challenges and little is known about perceptions of joining this type of program. This study qualitatively examined perceptions of advanced stage lung cancerpatients (n=14) participating in a lung cancer RTD program, their NoK (n=11), and physicians (n=6) at the Thoracic Oncology Clinic at H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida USA. METHODS: Semi-structured interviews were conducted with participants and interview transcripts were analyzed using the constant comparison method. RESULTS: Majority of patients joined to give back to research, discussed participation with family members, and desired for family to receive information about the use of the tissue after their death. All participating NoK were supportive of their family member's decision. Physicians described the program as running smoothly, but provided suggestions for process improvements. CONCLUSION:Participants joined with intention to give back to research community and families were supportive of loved one's participation in RTD. Physicians agreed with overall process. PRACTICE IMPLICATIONS: Key factors for a successful RTD program is tailoring to institutional and individual needs.
Authors: Sheri L Spunt; Sara O Vargas; Cheryl M Coffin; Stephen X Skapek; David M Parham; Joan Darling; Douglas S Hawkins; Charles Keller Journal: Cancer Date: 2011-10-17 Impact factor: 6.860
Authors: Kathryn Alsop; Heather Thorne; Shahneen Sandhu; Anne Hamilton; Christopher Mintoff; Elizabeth Christie; Odette Spruyt; Scott Williams; Orla McNally; Linda Mileshkin; Sumitra Ananda; Julene Hallo; Sherene Loi; Clare Scott; Peter Savas; Lisa Devereux; Patricia O'Brien; Sameera Gunawardena; Clare Hampson; Kate Strachan; Rufaro Diana Jaravaza; Victoria Francis; Gregory Young; David Ranson; Ravindra Samaranayake; David Stevens; Samantha Boyle; Clare Fedele; Monique Topp; Gwo Ho; Zhi Ling Teo; Renea A Taylor; Melissa M Papargiris; Mitchell G Lawrence; Hong Wang; Gail P Risbridger; Nicole M Haynes; Mikolaj Medon; Ricky W Johnstone; Eva Vidacs; Gisela Mir Arnau; Ismael A Vergara; Anthony T Papenfuss; Grant McArthur; Paul Waring; Shirley Carvosso; Christopher Angel; David Gyorki; Benjamin Solomon; Gillian Mitchell; Sue Shanley; Prudence A Francis; Sarah-Jane Dawson; Amy Haffenden; Erin Tidball; Mila Volchek; Jan Pyman; Mohammed Madadin; Jodie Leditschke; Stephen Cordner; Mark Shackleton; David D Bowtell Journal: Nat Biotechnol Date: 2016-09-12 Impact factor: 54.908
Authors: Matthew B Schabath; Jessica McIntyre; Christie Pratt; Luis E Gonzalez; Teresita Munoz-Antonia; Eric B Haura; Gwendolyn P Quinn Journal: J Med Ethics Date: 2013-04-04 Impact factor: 2.903
Authors: Tala Achkar; John Wilson; Jacqueline Simon; Margaret Rosenzweig; Shannon Puhalla Journal: Breast Cancer Res Treat Date: 2015-12-24 Impact factor: 4.872
Authors: Jamie Bryant; Rob Sanson-Fisher; Elizabeth Fradgley; Timothy Regan; Breanne Hobden; Stephen P Ackland Journal: BMC Cancer Date: 2015-05-17 Impact factor: 4.430
Authors: Theresa A Boyle; Gwendolyn P Quinn; Matthew B Schabath; Teresita Muñoz-Antonia; James J Saller; Luisa F Duarte; Laura S Hair; Jamie K Teer; Derek Y Chiang; Rebecca Leary; Connie C Wong; Alexander Savchenko; Angad P Singh; LaSalette Charette; Kate Mendell; Gullu Gorgun; Scott J Antonia; Alberto A Chiappori; Benjamin C Creelan; Jhanelle E Gray; Eric B Haura Journal: Cancer Med Date: 2019-11-20 Impact factor: 4.452